ArticleJournal of clinical medicine2024

A Prospective Randomized Controlled Clinical Study to Investigate the Efficacy and Safety of Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors in Non-Dialysis Patients with Chronic Heart Failure and Renal Anemia Switched from Continuous Erythropoietin Receptor Activator Treatment.

Akira Sezai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.